Noninferiority Margins in Clinical Trials-A Moving Target?

被引:0
|
作者
Wang, Li [1 ]
Torguson, Rebecca [1 ]
Farb, Andrew [1 ,2 ]
机构
[1] US FDA, Off Prod Evaluat & Qual, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA
[2] US FDA, Ctr Devices & Radiol Hlth, Off Cardiovasc Devices, 10903 New Hampshire Ave,16 WO66-2312, Silver Spring, MD 20993 USA
关键词
CORONARY INTERVENTION TRIALS; END-POINT DEFINITIONS;
D O I
10.1001/jamacardio.2021.5733
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:327 / 329
页数:4
相关论文
共 50 条
  • [1] Interpreting the results of noninferiority trials-a review
    Cuzick, Jack
    Sasieni, Peter
    [J]. BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1755 - 1759
  • [2] A systematic review of noninferiority margins in oncology clinical trials
    Hashim, Mahmoud
    Vincken, Talitha
    Kroi, Florint
    Gebregergish, Samron
    Spencer, Mike
    Wang, Jianping
    Kampfenkel, Tobias
    Lam, Annette
    He, Jianming
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (06) : 443 - 455
  • [3] The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents
    Powers, JH
    Ross, DB
    Brittain, E
    Albrecht, R
    Goldberger, MJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) : 879 - 881
  • [4] Using Patient Preferences to Determine Noninferiority Margins in Trials
    Feuer, Eric J.
    Jagsi, Reshma
    Lansdorp-Vogelaar, Iris
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2137 - 2138
  • [5] Noninferiority trials in clinical practice
    Marko, Monika
    Pawliczak, Rafal
    [J]. ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2019, 6 (04) : 152 - 159
  • [6] The Clinical Interpretation of Noninferiority Trials
    Roshanov, Pavel S.
    Khanna, Reena
    [J]. INFLAMMATORY BOWEL DISEASES, 2023,
  • [7] Principles for Defining Estimands in Clinical Trials-A Proposal
    Mutze, Tobias
    Bell, James
    Englert, Stefan
    Hougaard, Philip
    Jackson, Dan
    Lanius, Vivian
    Ravn, Henrik
    [J]. PHARMACEUTICAL STATISTICS, 2024,
  • [8] Hazard ratios in cancer clinical trials-a primer
    Blagoev, Krastan B.
    Wilkerson, Julia
    Fojo, Tito
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (03) : 178 - 183
  • [9] Using Patient Preferences to Determine Noninferiority Margins in Trials Reply
    Acuna, Sergio A.
    Chesney, Tyler R.
    Baxter, Nancy N.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (21): : 2138 - 2138
  • [10] Secondary Analysis of Clinical Trials-A Cautionary Note
    Marler, John R.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (04) : 335 - 337